Aspirin may boost ovarian cancer survival скачать в хорошем качестве

Aspirin may boost ovarian cancer survival

New QIMR Berghofer research has found that low-dose aspirin may improve ovarian cancer survival. The study followed more than 900 Australian women newly-diagnosed with ovarian cancer and asked them how often they used nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin. Lead researcher Doctor Azam Majidi said the women who reported taking NSAIDs at least four days a week in the 12 months after diagnosis, lived longer on average than occasional or non-users. Most of the frequent users were taking daily low-dose aspirin. Ovarian cancer can be hard to detect and usually isn’t discovered until stages three or four, when the five-year survival rate is just 29 per cent. Doctor Majidi said the findings offer hope that low-dose aspirin may help ovarian cancer survival at a population-wide level, while researchers continue to search for better therapies. However, she also stressed that aspirin is not safe for everyone so women should not start taking the drugs without consulting their doctor.